LogicBio Therapeutics - Ownership and Business Overview

Life ScienceCompany

LogicBio Therapeutics Ownership

Who owns LogicBio Therapeutics?

LogicBio Therapeutics is owned by Alexion Pharmaceuticals. It was acquired on October 3, 2022.

LogicBio Therapeutics Business Overview

Where is LogicBio Therapeutics headquartered?

LogicBio Therapeutics is headquartered in Lexington, Massachusetts.

What sector is LogicBio Therapeutics in?

LogicBio Therapeutics is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 288 acquisitions of life science companies in 2022, including 35 acquisitions by private equity firms, and 253 by strategics.

LogicBio Therapeutics

LogicBio Therapeutics, Inc.

65 Hayden Ave.,
Lexington, Massachusetts 02421
United States,
(617) 245-0399
www.logicbio.com

LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering genome editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood. LogicBio Therapeutics is based in Lexington, Massachusetts.


 Subscribe to unlock this and 202,225
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.